Clinical Trials Logo

Lymphangiomatosis clinical trials

View clinical trials related to Lymphangiomatosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02744027 Completed - Lymphatic Diseases Clinical Trials

Imaging of Lymphatic Anomalies

Start date: April 2016
Phase: N/A
Study type: Interventional

Lymphatic Anomalies (LA) is characterized by proliferation of lymphatic tissue causing deterioration of pulmonary function. Understanding changes in lymphatic anatomy in these patients is hindered by the difficulty of imaging the lymphatic system. Dynamic Contrast Enhanced MR Lymphangiogram (DCMRL) may be useful in investigating pathological changes in the lymphatic system.

NCT ID: NCT02399527 Recruiting - Clinical trials for Lymphatic Malformation

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Start date: June 2013
Phase:
Study type: Observational [Patient Registry]

Lymphatic anomalies are a rare subset of vascular anomalies that are poorly understood. the understanding of the natural history, long-term outcomes, risk factors for morbidity and mortality, and the relative benefit of medical therapies and procedures is limited.The goal of this project is to better understand these diseases and improve the care of theses rare patients. To do this, the investigators are conducting an observational study of patients with lymphatic anomalies, including an annual follow-up questionnaire to gather prospective data on mortality, morbidity, treatments, and functionality as well as quality of life.

NCT ID: NCT02156115 Terminated - Lymphedema Clinical Trials

Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders

Start date: March 23, 2015
Phase:
Study type: Observational

Background: - Lymphatics are a type of vessel, similar to arteries and veins. Lymphatic disorders happen when these vessels don t work properly. Researchers want to look for a relationship between lymphatic disorders and variations of certain genes found in the lung, blood, and other places in the body. Objective: - To learn more about lymphatic disorders and evaluate how genetic factors affect lymphatic disorders. Eligibility: - People ages 2 90 who have a lymphatic disorder or relatives of people with lymphatic disorders. - Healthy volunteers 18 and older. Design: - Participants may have 1 2 visits a year, or more as needed. The study is expected to last 5 years. Visits may last 1 5 days. Participants may have lab tests, medical history, and physical exam at each visit. - Participants may have blood testing that includes genetics tests, and urine tests. They may have nose and throat cultures, saliva collection, and cheek swabs to collect samples. - Participants may have a skin biopsy and have blood taken from an artery. - Participants may have breathing tests and be studied while exercising. - Participants may have an electrocardiogram. Electrodes will be placed on their chest, tracing heart rhythms. They may also have chest X-rays. - Participants may have a bronchoscopy. A thin, flexible instrument will be passed through the nose or mouth, into the lung. A tissue sample will be taken. - Participants who have lymphatic disease or have a relative with it may also have: - CT scans. They will lie on a table and hold their breath while their chest is scanned. - MRI. They will lie flat on a table that slides in and out of a scanner. - ultrasound. A probe is rolled around outside the abdomen. - removal of fluid around the lungs, chest, and abdomen.